Skip to main content
Premium Trial:

Request an Annual Quote

Idaho Tech Gets AOAC Nod for More Salmonella PCR Test Matrices


This article was originally published on April 20.

Idaho Technology said today that two additional matrices for its PCR-based Salmonella test have received Performance Tested Method approval from AOAC International.

Idaho Tech, based in Salt Lake City, Utah, received approval for stainless steel environmental samples and pet food. These join a list of already-approved matrices for use in the company's Salmonella LT kit, run on the RAPID LT Food Security System.

The assay uses real-time PCR to identify the presence of Salmonella in less than one hour after a pre-enrichment period, Idaho Tech said.

The RAPID LT Food Security System is built upon Idaho Tech's LightCycler technology, and combines rapid air thermocycling and real-time fluorimetry to test food and environmental samples.

"We have developed an easy, accurate, and timely PCR assay for detecting Salmonella in food and on surfaces," Kristine Clemens, a food safety validation manager at Idaho Tech, said in a statement. "We are thrilled to add these critical matrices to our AOAC approval, giving companies even more testing options."

Other approved matrices for the Salmonella LT kit include chocolate, cooked ham, fresh raw chicken, lettuce, raw ground beef, and liquid whole eggs, Idaho Tech said.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.